StockData
InfuSystem Holdings, Inc logo

InfuSystem Holdings, Inc (INFU) stock

INFUNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 13/303% above fair value
$14.06−0.61 (-4.16%)

Close on Nov 19, 2026Market cap $280.04MP/E 34.3Yield –

InfuSystem net income

Net income is the profit left for shareholders after every expense, interest and tax.

InfuSystem's net income for the twelve months ending Jun 30, 2026 was $8.54M, up 68.4% year over year. For fiscal 2025 it was $6.63M, up 182.6% from the year before. Over ten years it grew 9.1% a year on average. The highest annual figure on record is $17.33M in fiscal 2020.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$6.63M+182.6%
FY2024Dec 31, 2024$2.35M+168.9%
FY2023Dec 31, 2023$872.00K+4744.4%
FY2022Dec 31, 2022$18.00K-98.7%
FY2021Dec 31, 2021$1.42M-91.8%
FY2020Dec 31, 2020$17.33M+1173.5%
FY2019Dec 31, 2019$1.36M–
FY2018Dec 31, 2018-$1.10M–
FY2017Dec 31, 2017-$20.71M–
FY2016Dec 31, 2016-$222.00K-108.0%
FY2015Dec 31, 2015$2.79M-17.0%
FY2014Dec 31, 2014$3.36M+101.1%
FY2013Dec 31, 2013$1.67M–
FY2012Dec 31, 2012-$1.49M–
FY2011Dec 31, 2011-$45.44M–
FY2010Dec 31, 2010-$1.85M-339.3%
FY2009Dec 31, 2009$774.00K–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$3.23M+24.3%
Q1 FY2026Mar 31, 2026$1.02M–
Q4 FY2025Dec 31, 2025$2.04M+118.2%
Q3 FY2025Sep 30, 2025$2.26M+25.0%
Q2 FY2025Jun 30, 2025$2.60M+262.5%
Q1 FY2025Mar 31, 2025-$267.00K–
Q4 FY2024Dec 31, 2024$933.00K+1195.8%
Q3 FY2024Sep 30, 2024$1.81M+162.3%
Q2 FY2024Jun 30, 2024$717.00K+64.8%
Q1 FY2024Mar 31, 2024-$1.11M–
Q4 FY2023Dec 31, 2023$72.00K-32.7%
Q3 FY2023Sep 30, 2023$689.00K+55.5%
Q2 FY2023Jun 30, 2023$435.00K–
Q1 FY2023Mar 31, 2023-$324.00K–
Q4 FY2022Dec 31, 2022$107.00K-72.4%
Q3 FY2022Sep 30, 2022$443.00K–
Q2 FY2022Jun 30, 2022-$164.00K-120.0%
Q1 FY2022Mar 31, 2022-$368.00K-155.7%
Q4 FY2021Dec 31, 2021$387.00K-96.4%
Q3 FY2021Sep 30, 2021-$448.00K-115.2%
Q2 FY2021Jun 30, 2021$820.00K-80.2%
Q1 FY2021Mar 31, 2021$661.00K–
Q4 FY2020Dec 31, 2020$10.67M+1225.5%
Q3 FY2020Sep 30, 2020$2.94M+159.0%
Q2 FY2020Jun 30, 2020$4.14M+986.6%
Q1 FY2020Mar 31, 2020-$418.00K–
Q4 FY2019Dec 31, 2019$805.00K–
Q3 FY2019Sep 30, 2019$1.14M–
Q2 FY2019Jun 30, 2019$381.00K–
Q1 FY2019Mar 31, 2019-$960.00K-570.6%
Q4 FY2018Dec 31, 2018-$275.00K–
Q3 FY2018Sep 30, 2018-$519.00K–
Q2 FY2018Jun 30, 2018-$505.00K–
Q1 FY2018Mar 31, 2018$204.00K–
Q4 FY2017Dec 31, 2017-$17.99M–
Q3 FY2017Sep 30, 2017-$129.00K-330.4%
Q2 FY2017Jun 30, 2017-$1.11M–
Q1 FY2017Mar 31, 2017-$1.48M–
Q4 FY2016Dec 31, 2016-$472.00K–
Q3 FY2016Sep 30, 2016$56.00K–

More InfuSystem figures

See a number that looks wrong?